BridgeMD
New treatment option for Necrotizing Enterocolitis (NEC)
Official title Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach Based on Early Analysis of the Fecal Microbiota
ClinicalTrials.gov ID: NCT06727877
What this study is testing
- What it's testing
- Prematurity affects around 7% of births in France. Necrotizing enterocolitis (NEC) is a dreaded digestive complication.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 1. Healthy volunteers may be eligible.
You may be able to join if
- Child born prematurely (i.e. before 34 weeks of amenorrhea) in one of participating university hospitals and hospitalized in neonatal intensive care...
- Child born outside CHU and transferred before 24h of life to the neonatal intensive care unit of one of thehospital participating in the study
- Affiliated with a Social Security scheme
You likely can't join if
- Child whose guardians are protected by law (guardianship, curatorship, safeguard of justice)
- Children whose parents are under 18 years of age
- Refusal of parental authority to participate
The study team makes the final eligibility decision.
Where it's taking place
- Clermont-Ferrand, France
- Grenoble, France
- Lyon, France
- Saint-Etienne, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 1 day. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Clermont-Ferrand, France; Grenoble, France; Lyon, France; Saint-Etienne, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.